Schedule 13G ownership disclosure

Palvella Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 697947109

Event date: 2024-12-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Dellora Investments Master Fund LP

    Shares: 123,034.00 · Class: 1.1%

  • Dellora Investments LP

    Shares: 141,079.00 · Class: 1.3%

  • Kevin Pyun

    Shares: 141,079.00 · Class: 1.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001943462-24-000010
Form type
SCHEDULE 13G/A
Filer
Dellora Investments LP
CIK
CIK 1943462
Filed
Dec 17, 2024
Reporting period
Dec 13, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub